On Tuesday 26 November, the Habs Science Society welcomed by Dr Paul Mulholland, a neuroscientist at UCL.

Dr Mulholland leads a team of researchers, investigating cures for glioblastoma, the most aggressive form of brain cancer. His talk about the variety of previous failed treatments, along with the applications of Ipilimumab, the current leading medication for skin melanomas, gave the pupils a great insight into the field of medical research.

The talk also provided the students with a better understanding of the ethics behind experimental trials, as well as the processes involved in gaining funding such projects.

Overall, Dr Mulholland’s talk proved to be very thought provoking, especially for the budding doctors and scientists attending.